Insights

Innovative Focus Neobiosis specializes in isolating tissues, cells, and extracellular vesicles from perinatal tissues for therapeutic and regenerative medicine applications, presenting opportunities to partner on cutting-edge bioproduct development and clinical trials.

Market Expansion With a revenue range of 10 to 25 million dollars and a focus on FDA-approved clinical trial processes, Neobiosis is positioned to expand into global markets seeking advanced regenerative medicine products derived from perinatal tissues.

Research & Development The company's commitment to building an in-house pipeline of biological products for anti-aging suggests collaboration prospects in innovative biotech and anti-aging markets, appealing to clients investing in breakthrough therapies.

Facility Capacity Located with two production facilities and a R&D lab in Gainesville, Neobiosis offers scalable manufacturing and research collaboration opportunities to support growing demand in the regenerative medicine sector.

Technology Stack Utilizing modern technologies like WordPress, MySQL, and OpenResty, Neobiosis demonstrates strong technical infrastructure, facilitating partnerships focused on bioinformatics, data management, and digital solutions in biotech development.

Neobiosis Tech Stack

Neobiosis uses 8 technology products and services including WordPress, MySQL, jQuery Migrate, and more. Explore Neobiosis's tech stack below.

  • WordPress
    Content Management System
  • MySQL
    Database
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Lua
    Programming Languages
  • reCAPTCHA
    Security
  • GoDaddy
    Web Hosting
  • OpenResty
    Web Servers

Media & News

Neobiosis's Email Address Formats

Neobiosis uses at least 1 format(s):
Neobiosis Email FormatsExamplePercentage
First@neobiosis.comJohn@neobiosis.com
48%
FLast@neobiosis.comJDoe@neobiosis.com
2%
First.Last@neobiosis.comJohn.Doe@neobiosis.com
2%
First@neobiosis.comJohn@neobiosis.com
48%

Frequently Asked Questions

Where is Neobiosis's headquarters located?

Minus sign iconPlus sign icon
Neobiosis's main headquarters is located at Gainesville, Florida United States. The company has employees across 2 continents, including North AmericaEurope.

What is Neobiosis's official website and social media links?

Minus sign iconPlus sign icon
Neobiosis's official website is neobiosis.com and has social profiles on LinkedIn.

What is Neobiosis's SIC code NAICS code?

Minus sign iconPlus sign icon
Neobiosis's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Neobiosis have currently?

Minus sign iconPlus sign icon
As of February 2026, Neobiosis has approximately 16 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer And Chief Scientific Officer: I. W.Chief Financial Officer: D. P.Director Strategic Development: K. H.. Explore Neobiosis's employee directory with LeadIQ.

What industry does Neobiosis belong to?

Minus sign iconPlus sign icon
Neobiosis operates in the Biotechnology Research industry.

What technology does Neobiosis use?

Minus sign iconPlus sign icon
Neobiosis's tech stack includes WordPressMySQLjQuery MigratejQueryLuareCAPTCHAGoDaddyOpenResty.

What is Neobiosis's email format?

Minus sign iconPlus sign icon
Neobiosis's email format typically follows the pattern of First@neobiosis.com. Find more Neobiosis email formats with LeadIQ.

When was Neobiosis founded?

Minus sign iconPlus sign icon
Neobiosis was founded in 2020.

Neobiosis

Biotechnology ResearchFlorida, United States11-50 Employees

Neobiosis, LLC is a privately owned, clinical stage, biomedical contract development and manufacturing organization (CDMO) with two production facilities in downtown Gainesville and a Research & Development laboratory located within the Sid Martin UF Innovate biotechnology Institute in Alachua, FL. The focus of Neobiosis is the isolation of tissues, cells and extracellular vesicles (EVs), with medicinal potential, from donated perinatal (birth) tissues, including umbilical cord, umbilical cord blood and amniotic fluid. The name Neobiosis ("new life") is derived from a series of experiments called Parabiosis ("living together") where it was discovered that tissues, cells and EVs from a young donor could be used to promote the healing of older individuals. Neobiosis produces innovative products from healthy, full-term births, for client organizations who wish to take biomedical products though FDA-approved clinical trials for commercialization in a global market. Neobiosis is also committed to advancing an in-house pipeline of intellectual property and biologicals for use in anti-aging and regenerative medicine.

Section iconCompany Overview

Headquarters
Gainesville, Florida United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    Neobiosis's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Neobiosis's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.